title: [Treatment of pulmonary artery hypertensions].
abstract: The pulmonary hypertension (PAH) in chronic obstructive lung disease include therapy of the respiratory disease i.e. bronchodilator, kinesitherapy. Long-term oxygen therapy (more than 15 h/day) reverse the course of PAH and increase survey. Long-term efficiency of vasodilators is not well demonstrated. Primary PAH could benefit from vasodilators, especially waiting lung or heart-lung transplantation. Patients with PAH secondary to respiratory insufficiency could also be successfully transplanted. In post embolic PAH, antithrombotic agents are useful. Thrombectomy or transplantation are sometimes proposed.
authors.affiliation: Service de pneumologie CHU Nord, Marseille.
authors.forename: F
authors.initials: F
authors.lastname: Philip-Joet
authors.forename: A
authors.initials: A
authors.lastname: Saadjian
authors.forename: M
authors.initials: M
authors.lastname: Reynaud-Gaubert
authors.forename: A
authors.initials: A
authors.lastname: Arnaud
mesh_terms: D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000628:therapy; D011655:Pulmonary Embolism / Q000150:complications; D012131:Respiratory Insufficiency / Q000150:complications
vernacular_title: Traitement des hypertensions artérielles pulmonaires.